nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—EDNRA—Prostaglandin Synthesis and Regulation—HSD11B2—type 1 diabetes mellitus	0.143	0.156	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelin Pathways—ADRB1—type 1 diabetes mellitus	0.0547	0.0596	CbGpPWpGaD
Sulfisoxazole—EDNRA—EGFR-dependent Endothelin signaling events—EGFR—type 1 diabetes mellitus	0.0443	0.0482	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Other—CHRM2—type 1 diabetes mellitus	0.0331	0.0361	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—PRKCQ—type 1 diabetes mellitus	0.0281	0.0306	CbGpPWpGaD
Sulfisoxazole—Sulfamethazine—ALB—type 1 diabetes mellitus	0.0259	0.316	CrCbGaD
Sulfisoxazole—Sulfamerazine—ALB—type 1 diabetes mellitus	0.0253	0.309	CrCbGaD
Sulfisoxazole—EDNRA—Endothelin Pathways—NOS3—type 1 diabetes mellitus	0.0241	0.0263	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—GAL—type 1 diabetes mellitus	0.0198	0.0215	CbGpPWpGaD
Sulfisoxazole—Sulfamethizole—ALB—type 1 diabetes mellitus	0.0196	0.24	CrCbGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CCL11—type 1 diabetes mellitus	0.0196	0.0213	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CCL20—type 1 diabetes mellitus	0.0196	0.0213	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide GPCRs—CCR5—type 1 diabetes mellitus	0.0186	0.0202	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—ITPR3—type 1 diabetes mellitus	0.0167	0.0182	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Other—CCR5—type 1 diabetes mellitus	0.0157	0.0171	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR3—type 1 diabetes mellitus	0.0149	0.0163	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.0144	0.0157	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—SST—type 1 diabetes mellitus	0.0136	0.0148	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.0133	0.0144	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.0131	0.0143	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.0131	0.0143	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.0123	0.0134	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	0.0122	0.0133	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	0.0118	0.0128	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.0113	0.0123	CbGpPWpGaD
Sulfisoxazole—Sulfamethoxazole—ALB—type 1 diabetes mellitus	0.011	0.135	CrCbGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	0.0109	0.0119	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.0106	0.0115	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.0105	0.0115	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.0101	0.011	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00999	0.0109	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00999	0.0109	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00939	0.0102	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00909	0.0099	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00905	0.00986	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00873	0.00951	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00846	0.00921	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00788	0.00859	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00755	0.00823	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00692	0.00754	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00689	0.0075	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00684	0.00745	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00617	0.00672	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00586	0.00638	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00575	0.00626	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00571	0.00622	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00564	0.00615	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.00549	0.00598	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00531	0.00578	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00518	0.00564	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00512	0.00558	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00512	0.00558	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00482	0.00525	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00476	0.00519	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00446	0.00486	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00446	0.00485	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00433	0.00471	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00405	0.00441	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00391	0.00426	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00389	0.00424	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00355	0.00387	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00354	0.00385	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00353	0.00385	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.0035	0.00381	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00349	0.0038	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.00336	0.00365	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00326	0.00355	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00325	0.00354	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00317	0.00345	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GAL—type 1 diabetes mellitus	0.00306	0.00333	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00305	0.00332	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00303	0.0033	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00303	0.0033	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00296	0.00322	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00295	0.00321	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00285	0.0031	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.00269	0.00293	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.00256	0.00278	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00252	0.00275	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00248	0.00271	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00241	0.00262	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00239	0.0026	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00239	0.0026	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00229	0.00249	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.00226	0.00246	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SST—type 1 diabetes mellitus	0.0021	0.00229	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00209	0.00228	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00187	0.00204	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.0018	0.00196	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.00175	0.0019	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.00174	0.0019	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.00159	0.00173	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00158	0.00172	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00152	0.00166	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.00146	0.00159	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.00145	0.00158	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00138	0.0015	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.00137	0.0015	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.00135	0.00147	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.00133	0.00145	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.00132	0.00144	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	0.00121	0.00132	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	0.00114	0.00124	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CD80—type 1 diabetes mellitus	0.00111	0.00121	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—INS—type 1 diabetes mellitus	0.00105	0.00114	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.00102	0.00111	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.00101	0.0011	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	0.000985	0.00107	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000939	0.00102	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000922	0.001	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000782	0.000852	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000781	0.000851	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000779	0.000848	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000777	0.000847	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	0.000657	0.000716	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000657	0.000716	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	0.000619	0.000674	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	0.000615	0.00067	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	0.000604	0.000658	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000598	0.000651	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000557	0.000606	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	0.000481	0.000524	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000459	0.0005	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	0.000407	0.000444	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	0.00027	0.000294	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	0.000248	0.00027	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	0.000237	0.000258	CbGpPWpGaD
